CP-461 in the Treatment of Patients With Advanced Melanoma

Clinical trial NCT00060710 · TERMINATED

Trial details

NCT number: NCT00060710
Sponsor: Astellas Pharma Inc
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Melanoma

Start date: 2003-01-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.